Anti-KIRD2 Subgroup Recombinant Antibody (TAB-757)

CAT#: TAB-757

Recombinant human monoclonal antibody expressed in CHO binding to human KIRD2 subgroup. It is a human monoclonal antibody designed for the treatment of cancer.

Tested Data
Figure 1 Anti-KIRD2 Subgroup Antibody (Lirilumab) (TAB-757) in ELISA Figure 2 Anti-KIRD2 Subgroup Recombinant Antibody (TAB-757) in SDS-PAGE Figure 3 Anti-KIRD2 Subgroup Recombinant Antibody (TAB-757) in HPLC

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG4 - kappa
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, ICC and most other immunological methods.
  • MW
  • 145.2 kDa
  • Related Disease
  • Acute myeloid leukemia (AML)

Product Property

  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

Target

  • Alternative Names
  • lirilumab;1000676-41-4;IPH 2101;IPH2101;1-7F9;IPH 2102;IPH2102;BMS-986015;Killer-cell immunoglobulin-like receptors;KIRs;KIR2DL1/2/3
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-757. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-757, RRID: AB_3112004)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Lirilumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Lirilumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "KIRD2"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NAB-1602-sdAb Recombinant Anti-Human KIRD2 VHH Single Domain Antibody WB, ICC, ChiP, FA, ELISA Llama VHH
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare